Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5+ colorectal cancer
2020 · Cell Death and Disease · 72 citations
https://doi.org/10.1038/s41419-020-03111-7
X
Xiaonan Shen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
498
Citations
11
h-index
15
i10-index
Xiaonan Shen is an academic researcher from Jiangsu University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cancer-related molecular mechanisms research & Colorectal Cancer Screening and Detection. The author has an h-index of 11, co-authored 30 publications.
Papers by this author
worksCircHAS2 activates CCNE2 to promote cell proliferation and sensitizes the response of colorectal cancer to anlotinib
2024 · Molecular Cancer · 22 citations
https://doi.org/10.1186/s12943-024-01971-7
Ferroptosis: A new view on the prevention and treatment of diabetic kidney disease with traditional Chinese medicine
2023 · Biomedicine & Pharmacotherapy · 19 citations
https://doi.org/10.1016/j.biopha.2023.115952
A Data-driven and Deep Learning-based Mid- and Long-term Electric Vehicle Charging Load Forecasting Method
2025 · Recent Advances in Electrical & Electronic Engineering (Formerly Recent Patents on Electrical & Electronic Engineering) · 0 citations
https://doi.org/10.2174/0123520965389850250505070220
A multi-source feature engineering-enhanced framework for mid-to-long-term EV charging load forecasting: Integrating self-adaptive optimization and BiLSTM-iTransformer predictor
2025 · Energy · 0 citations
https://doi.org/10.1016/j.energy.2025.139020
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat